Benefit of Adding Ibrutinib to Bendamustine/Rituximab as Frontline Treatment for Mantle Cell Lymphoma: First Phase III Trial Changing the Paradigm for the Care of Elderly Patients ...Middle East

News by : (PR Newswire) -
John Theurer Cancer Center Investigators Participate in Large Pivotal International Study HACKENSACK, N.J., June 3, 2022 /PRNewswire/ -- Hackensack Meridian John Theurer Cancer Center investigators participated in the large phase III multicenter SHINE study, which reported that using the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Benefit of Adding Ibrutinib to Bendamustine/Rituximab as Frontline Treatment for Mantle Cell Lymphoma: First Phase III Trial Changing the Paradigm for the Care of Elderly Patients )

Also on site :

Most Viewed News
جديد الاخبار